Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis

Vertebral osteoporosis, a common disorder in elderly women, is characterized by a wide spectrum of bone turnover abnormalities on iliac crest biopsy. The level of bone formation can be assessed noninvasively by measuring serum osteocalcin, whereas conventional biochemical markers of bone resorption lack specificity and do not reflect bone resorption assessed from histology. We measured the urinary excretion of pyridinoline crosslinks Pyr and D‐Pyr, a specific marker of bone and cartilage collagen degradation, along with serum osteocalcin and urinary hydroxyproline, in 36 elderly women with vertebral osteoporosis who had a simultaneous iliac crest biopsy. Urinary pyridinoline crosslinks, but not hydroxyproline, correlated significantly with histologic resorption, assessed by the osteoclast surface (r = 0.35, p < 0.05 for Pyr; r = 0.46, p < 0.01 for D‐Pyr). In addition, Pyr and D‐Pyr were correlated with the bone formation rate as well as serum osteocalcin, with correlation coefficients ranging from 0.69 to 0.80, p < 0.0001. These data indicate that Pyr and D‐Pyr are sensitive markers of bone turnover in elderly women with vertebral osteoporosis. The poor correlation between the level of urinary collagen crosslinks and histological assessment of bone resorption indicates the low sensitivity of iliac crest histomorphometry in the measurement of resorption rate of the skeleton.

[1]  C. Christiansen,et al.  Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. , 1991, The Journal of clinical endocrinology and metabolism.

[2]  P. Delmas,et al.  Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. , 1990, Endocrinology and metabolism clinics of North America.

[3]  D. Uebelhart,et al.  Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. , 1990, Bone and mineral.

[4]  M. Seibel,et al.  Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. , 1989, The Journal of rheumatology.

[5]  D. Baylink,et al.  Biochemical Markers For Bone Formation and Bone Resorption , 1989 .

[6]  L. Avioli,et al.  Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. , 1988, The Journal of clinical investigation.

[7]  C. Christiansen,et al.  Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women , 1988, European journal of clinical investigation.

[8]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  J. Pødenphant,et al.  Bone turnover in spinal osteoporosis , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  S L Hui,et al.  Sex steroids and bone mass. A study of changes about the time of menopause. , 1987, The Journal of clinical investigation.

[11]  P. Delmas,et al.  Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis. , 1987, The Journal of clinical endocrinology and metabolism.

[12]  C. Christiansen,et al.  A radioimmunoassay for bone Gla protein (BGP) in human plasma. , 1987, Acta endocrinologica.

[13]  D. Eyre [7] Collagen cross-linking amino acids , 1987 .

[14]  J. Stepan,et al.  Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women. , 1987, Bone.

[15]  E. Eriksen,et al.  Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. , 1986, Endocrine reviews.

[16]  C. Christiansen,et al.  Comparison of single- and dual-photon absorptiometry in postmenopausal bone mineral loss. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  J. Pødenphant,et al.  An easy and reliable method for determination of urinary hydroxyproline. , 1984, Clinica chimica acta; international journal of clinical chemistry.

[18]  P. Delmas,et al.  SERUM BONE GLA-PROTEIN: A SPECIFIC MARKER FOR BONE FORMATION IN POSTMENOPAUSAL OSTEOPOROSIS , 1984, The Lancet.

[19]  D Fujimoto,et al.  The structure of pyridinoline, a collagen crosslink. , 1978, Biochemical and biophysical research communications.

[20]  A. Struyvenberg,et al.  BLOOD-LIPIDS IN RENAL DISEASE , 1975, The Lancet.